“Graves’ Disease Market” report has been added to DelveInsight
Graves’ disease Overview
Graves ‘disease is a common form of hyperthyroidism. In this autoimmune disease, the immune system creates antibodies known as thyroid-stimulating immunoglobulins. They then attach to healthy thyroid cells thus, causing one’s thyroid to create too much thyroid hormone.
Graves’ disease Market Insights
DelveInsight’s “Graves’ Disease – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Graves’ Disease, historical and forecasted epidemiology as well as the Graves’ Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Request free sample copy@ https://www.delveinsight.com/sample-request/graves-disease-market
Graves’ disease Market: By Regions Covered
- The United States
- EU5 (Germany, France, Italy, Spain, and the United Kingdom)
Graves’ disease Key Player
Graves’ disease Drug
Graves’ disease Risk Factors
Risk factor for Graves’ disease includes having a family history, an autoimmune disease, celiac disease, hormone disorder, Pernicious anemia and vitiligo. Hand tremors, weight loss, rapid heart rate, intolerance to heat, fatigue, nervousness, irritability, muscle weakness, goiter, difficult sleeping and frequent formed bowel movements are some of the symptoms shared by individuals affected with Graves’ disease and hyperthyroidism.
Graves’ disease Pathophysiology
Pathophysiology of autoimmune Graves’ disease is still unknown. It is believed that these disorders probably develop from a combination of genes and an outside trigger, such as a virus. An enlarged thyroid, signs of Graves’ eye disease— present in about one out of three people with Graves’ disease, a history of other family members with thyroid or autoimmune problems helps in diagnosis. In case of uncertainty, blood tests or imaging can be ordered to confirm.
Graves’ disease Treatment
Treatment includes the intake of radioactive iodine therapy by mouth, medications (anti-thyroid medications and betablockers) and surgery which is a less common choice. Anti-thyroid medications such as, methimazole (Tapazole) and propylthiouracil block the gland’s production of thyroid hormone.
There are two goals in the treatment for Graves’ disease. One is to stop the thyroid gland from overproducing thyroid hormone. The other is to stop the increased levels of thyroid hormone from causing problems in the body. There are a number of treatment options to achieve one or both of these goals.
Graves’ disease Market Report
Thyroid hormones affects various aspects of nervous system function, brain development, body temperature and other important elements. If left untreated, it causes weight loss, anxiety, jitteriness, irritability, depression, and mental or physical fatigue. Apart from these, other complications include eye problems, heart problems, skin problems etc.
Graves’ disease Treatment Market
There are three treatment options for the individuals affected with Graves’ disease viz; medicine, radioiodine therapy and thyroid surgery. Radioiodine therapy is the most common treatment for Graves’ disease in the United States, but doctors are beginning to use medicine more often than in the past. Age, Pregnancy, presence of other medical conditions determines the right treatment for the patients.
Graves’ disease Market Research
The conventional therapeutic options for Graves’ disease have not improved over the past 70 years, despite substantial unmet clinical need and a significant lack of efficacy for many patients. The demand for innovative therapeutic options has led to the emergence of novel approaches in the treatment of Graves’ hyperthyroidism, including biologic, small molecule, and peptide immunomodulation, several of which have translational potential into clinical practice in the near future.
Graves’ disease Emerging Therapy
The current emerging landscape for Graves ‘disease is scarce mainly comprising of candidate drugs for Thyroid Eye Disease. The key players are Novartis, Apitope and others.
Table of content
1. Key Insights
2. Executive Summary of Graves’ Disease
3. Competitive Intelligence Analysis for Graves’ Disease
4. Graves’ Disease: Market Overview at a Glance
5. Graves’ Disease: Disease Background and Overview
6. Patient Journey
7. Graves’ Disease Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of Graves ‘disease Treatment
11. Marketed Products
12. Emerging Therapies
13. Graves’ Disease: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Graves ‘disease
17. KOL Views
18. Market Drivers
19. Market Barriers
21. DelveInsight Capabilities
23. About DelveInsight
Why should you buy this report?
- The report will help in developing business strategies by understanding trends shaping and driving the Graves’ Disease market
- To understand the future market competition in the Graves’ Disease market and Insightful review of the key market drivers and barriers
- Organize sales and marketing efforts by identifying the best opportunities for Graves’ Disease in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
- Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
- Organize sales and marketing efforts by identifying the best opportunities for Graves’ Disease market
- To understand the future market competition in the Graves’ Disease market
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for life science vertical and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Address:304 S. Jones Blvd #2432
City: Las Vegas
Country: United States